Biotricity Inc. (BTCY): FDA should push price past 4.50

Reply Private New

Next 10 Prev Next

Send PM Follow Ignore

Re: None

Sunday, 03/14/2021 6:55:21 PM

Sunday, March 14, 2021 6:55:21 PM

FDA should push price past 4.50

Keep Last Read

Next 10 Prev Next

Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 02/20/2024 10:02:19 PM
Form NT 10-Q - Notification of inability to timely file Form 10-Q or 10-QSB • Edgar (US Regulatory) • 02/14/2024 10:18:47 PM
Form 8-K - Current report • Edgar (US Regulatory) • 02/02/2024 10:30:24 PM
Form 8-K - Current report • Edgar (US Regulatory) • 11/06/2023 09:55:34 PM
SWK Holdings Highlights Recent Achievements and Provides Portfolio Update • PR Newswire (US) • 10/18/2023 12:00:00 PM
Form 8-K - Current report • Edgar (US Regulatory) • 09/20/2023 12:15:04 PM
Form 424B5 - Prospectus [Rule 424(b)(5)] • Edgar (US Regulatory) • 09/19/2023 08:57:08 PM
Form 8-K - Current report • Edgar (US Regulatory) • 08/17/2023 12:38:08 PM
Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/14/2023 08:26:10 PM
Form 8-K - Current report • Edgar (US Regulatory) • 08/04/2023 08:15:22 PM
Form 8-K - Current report • Edgar (US Regulatory) • 07/20/2023 09:14:24 PM
SWK Holdings Highlights Recent Achievements and Provides Portfolio Update • PR Newswire (US) • 07/17/2023 08:05:00 PM
Form 8-K - Current report • Edgar (US Regulatory) • 07/05/2023 08:05:35 PM
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405] • Edgar (US Regulatory) • 06/29/2023 09:29:39 PM

InvestorsHub NewsWire

Only $200 per official company press release!